Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's expanding ...
The launch marks the first medical cannabis products Aphria RX has grown under the medical cannabis cultivation license ...
Zuanic & Associates rates Tilray "Neutral," noting long-term potential but near-term uncertainties, despite cannabis growth ...
Medical, a division of Tilray Brands, announced the launch of its first commercial German grown medical cannabis flowers from its ...
Q1 was way below expectations, and the outlook has been diminished. The stock looks expensive to peers. Find out why TLRY ...
Shares of Tilray Brands Inc. TLRY shed 2.04% to $1.44 Wednesday, on what proved to be an all-around mixed trading session for ...
Blue Point Brewing Company, a subsidiary of Tilray Brands, announces Blitz Beer, a new American Lager added to Blue Point’s winter seasonal lineup. Available November through Fe ...
Hosted on MSN19h
Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer American Lager and Hosts The Blue Point Blitz Celebration at Webster HallNEW YORK, NY Nov. 14, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island’s original craft brewery and a ...
Barchart on MSN2d
Is Tilray Stock a Buy on Positive Cannabis Data?Real-time index price for Nasdaq Bank Index (BANK), along with buy or sell indicators, analysis, charts, historical ...
7don MSN
On Thursday, Tilray Medical, a division of medical marijuana giant Tilray Brands, Inc. (NASDAQ:TLRY), announced the final ...
Wealth Enhancement Advisory Services LLC increased its holdings in shares of Tilray Inc (NASDAQ:TLRY – Free Report) by 22.6% during the 3rd quarter, according to the company in its most recent 13F ...
Tilray Brands Inc. is trying to trick investors for a second straight year into increasing its share limit, according to a lawsuit against the Canadian cannabis company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback